In April 2020, almost 4 decades after ranitidine (Zantac) was approved by the FDA, the agency
ordered it and all its generics taken off the market.
This decision was due to the well-known carcinogenic effects of an impurity
(N-nitrosodimethylamine or NDMA) contaminating Zantac at extremely high dangerous levels.
But NDMA didn’t just recently make its way into the drug. Instead, NDMA is inherent in
ranitidine at the molecular level. So it has been there all along.
When Zantac was on the market, the drug companies GlaxoSmithKline, Sanofi, Boehringer
Ingelheim (and dozens of other generic companies) raked in billions of dollars in profits while
failing to warn consumers of the potential dangers.
There are millions of people in the United States who have used ranitidine regularly for
heartburn. Because of this, the size of potential claimants for Zantac cases could be the largest in
history. There can be no doubt these victims will continue to seek the help of qualified legal
professionals for many years to come.
Legal Calls is here to help your firm acquire these mass tort cases. We can send you signed
Zantac retainers ready to litigate right now.
If you are ready to start growing your business, get in touch with us today.